Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer.

The serine/threonine protein phosphatase 5 (PP5) regulates multiple cellular signaling networks. A number of cellular factors, including heat shock protein 90 (Hsp90), promote the activation of PP5. However, it is unclear whether post-translational modifications also influence PP5 phosphatase activity. Here, we show an "on/off switch" mechanism for PP5 regulation. The casein kinase 1δ (CK1δ) phosphorylates T362 in the catalytic domain of PP5, which activates and enhances phosphatase activity independent of Hsp90. Overexpression of the phosphomimetic T362E-PP5 mutant hyper-dephosphorylates substrates such as the co-chaperone Cdc37 and glucocorticoid receptor in cells. Our proteomic approach revealed that the tumor suppressor von Hippel-Lindau protein (VHL) interacts with and ubiquitinates K185/K199-PP5 for proteasomal degradation in a hypoxia- and prolyl-hydroxylation-independent manner. Finally, VHL-deficient clear cell renal cell carcinoma (ccRCC) cell lines and patient tumors exhibit elevated PP5 levels. Downregulation of PP5 causes ccRCC cells to undergo apoptosis, suggesting a prosurvival role for PP5 in kidney cancer.

[1]  Mehdi Mollapour,et al.  Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors. , 2016, Advances in cancer research.

[2]  Hua Yu,et al.  Inhibition of protein phosphatase 5 (PP5) suppresses survival and growth of colorectal cancer cells , 2015, Biotechnology and applied biochemistry.

[3]  S. Sen,et al.  Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL , 2017, Oncogene.

[4]  G. Fink,et al.  Methods in yeast genetics , 1979 .

[5]  D. Armstrong,et al.  Activated Rac1 GTPase Translocates Protein Phosphatase 5 to the Cell Membrane and Stimulates Phosphatase Activity in Vitro* , 2009, The Journal of Biological Chemistry.

[6]  P. Ratcliffe,et al.  The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma , 2001, Oncogene.

[7]  A. Kibel,et al.  Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.

[8]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[9]  D. Barford,et al.  Molecular basis for TPR domain‐mediated regulation of protein phosphatase 5 , 2005, The EMBO journal.

[10]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[11]  G. Popowicz,et al.  Selective activators of protein phosphatase 5 target the auto-inhibitory mechanism , 2015, Bioscience reports.

[12]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[13]  A. Sancar,et al.  Posttranslational regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5 , 2006, Proceedings of the National Academy of Sciences.

[14]  E. Maher,et al.  VHL, the story of a tumour suppressor gene , 2014, Nature Reviews Cancer.

[15]  Guofei Zhou,et al.  Ser/Thr Protein Phosphatase 5 Inactivates Hypoxia-induced Activation of an Apoptosis Signal-regulating Kinase 1/MKK-4/JNK Signaling Cascade* , 2004, Journal of Biological Chemistry.

[16]  B. Schittek,et al.  Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis , 2014, Molecular Cancer.

[17]  N. Dean,et al.  Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. , 1999, Biochemistry.

[18]  D. Bourboulia,et al.  Structural and functional basis of protein phosphatase 5 substrate specificity , 2016, Proceedings of the National Academy of Sciences.

[19]  K. Gross,et al.  Identification of amino acids in the tetratricopeptide repeat and C-terminal domains of protein phosphatase 5 involved in autoinhibition and lipid activation. , 2001, Biochemistry.

[20]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[21]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[22]  R. Honkanen,et al.  The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer , 2008, Cancer and Metastasis Reviews.

[23]  W Marston Linehan,et al.  Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics , 2012, Genome research.

[24]  P. Graves,et al.  Phosphate groups as substrate determinants for casein kinase I action. , 1990, The Journal of biological chemistry.

[25]  T. Madl,et al.  The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90 , 2015, Scientific Reports.

[26]  R. Winn,et al.  The soft agar colony formation assay. , 2014, Journal of visualized experiments : JoVE.

[27]  Mirna Lechpammer,et al.  Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. , 2002, Cancer cell.

[28]  R. Conaway,et al.  Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Yigong Shi.  Serine/Threonine Phosphatases: Mechanism through Structure , 2009, Cell.

[30]  L. Neckers,et al.  Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity. , 2013, Future medicinal chemistry.

[31]  W. Kaelin,et al.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.

[32]  Michael Chinkers,et al.  Identification of potential physiological activators of protein phosphatase 5. , 2002, Biochemistry.

[33]  L. Pearl,et al.  Hsp90-Dependent Activation of Protein Kinases Is Regulated by Chaperone-Targeted Dephosphorylation of Cdc37 , 2008, Molecular cell.

[34]  J. Buchner,et al.  The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90 , 2006, The EMBO journal.

[35]  S. Landas,et al.  Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors , 2016, Cell reports.

[36]  R. Samant,et al.  Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer. , 2008, Biochimica et biophysica acta.

[37]  L. Pearl,et al.  Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. , 2010, Molecular cell.

[38]  N. Dean,et al.  Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest* , 1998, The Journal of Biological Chemistry.

[39]  E. Zuiderweg,et al.  Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. , 2013, ACS medicinal chemistry letters.

[40]  M. Mayer,et al.  Hsp90: breaking the symmetry. , 2015, Molecular cell.

[41]  D. Barford,et al.  Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. , 2006, Structure.

[42]  Y. Miyata,et al.  Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. , 2012, Molecular cell.

[43]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.